Top compounds associated with response to CLDN34

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Teniposide	CTRPv2	pan-cancer	AAC	-0.025	0.5
mRNA	BMS-536924	CTRPv2	pan-cancer	AAC	0.022	0.5
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.022	0.5
mRNA	SNX-2112:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.02	0.5
mRNA	BMS-754807	CTRPv2	pan-cancer	AAC	0.022	0.5
mRNA	docetaxel:tanespimycin (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.02	0.6
mRNA	MS-275	CTRPv2	pan-cancer	AAC	0.019	0.6
mRNA	vorapaxar	CTRPv2	pan-cancer	AAC	-0.023	0.6
mRNA	tandutinib	CTRPv2	pan-cancer	AAC	-0.022	0.6
mRNA	Repligen 136	CTRPv2	pan-cancer	AAC	-0.022	0.6

Download CSV